Stereotactic Radiosurgery Greatest Achievement in Radiation Oncology

by | Jul 10, 2026 | Radiosurgery

Stereotactic Radiosurgery (SRS) The Art of Delivering an Ablative Dose with Sub-Millimeter Precision ~ CyberKnife, also known as Stereotactic Radiosurgery (SRS) is one of the greatest achievements in modern radiation oncology. Despite the name “Radiosurgery”, it is not a surgical procedure. No scalpel is used, no incision is made, and no tissue is physically removed.
Instead, SRS delivers a very high dose of ionizing radiation to a precisely defined target in a single treatment session, while minimizing the dose to surrounding normal tissues.
The concept is simple:
Destroy the lesion with radiation as accurately as a neurosurgeon would remove it with a scalpel.
This is why Lars Leksell, the pioneer of stereotactic radiosurgery, described radiation as an “invisible surgical knife.”
Historical Background
The concept of SRS was introduced by Swedish neurosurgeon Professor Lars Leksell in 1951.
His goal was to treat intracranial lesions without opening the skull.
At that time, treatment was performed using the Gamma Knife, which utilized multiple Cobalt-60 sources focused on a single intracranial point.
Today, SRS can also be delivered using:
LINAC-based systems
CyberKnife
Gamma Knife
Although the delivery technology differs, the biological principle remains the same:
Deliver an extremely high dose with extreme geometric accuracy.
What Makes SRS Different from Conventional Radiotherapy?
Traditional external beam radiotherapy typically delivers:
1.8–2 Gy per fraction
over 25–40 fractions.
SRS is fundamentally different.
Instead of spreading the dose over several weeks, SRS delivers:
15 Gy
18 Gy
20 Gy
24 Gy
or even higher doses
in a single fraction.
This approach creates a very high Biologically Effective Dose (BED), resulting in excellent local tumor control.
Why Can We Give Such High Doses?
Delivering 20 Gy in one fraction would be unacceptable using conventional techniques.
Normal brain tissue would receive an excessive dose.
SRS becomes possible because of:
Sub-millimeter localization
Sharp dose gradients
Highly conformal dose distributions
Advanced immobilization
High-quality image guidance
The prescription dose falls off rapidly outside the target, sparing nearby critical structures.
Principles of SRS
Every SRS treatment depends on five essential principles.
1. Stereotactic Localization
The exact three-dimensional coordinates of the lesion must be determined.
Historically, this was achieved using a rigid stereotactic frame.
Modern systems often use frameless immobilization with image guidance.
2. High-Resolution Imaging
Planning usually requires:
Thin-slice CT Simulation (≤1 mm)
Contrast-enhanced MRI
Sometimes CT angiography or functional MRI
MRI fusion is essential because MRI defines intracranial anatomy far better than CT.
3. Precise Target Delineation
The target must be contoured with extreme accuracy.
In SRS, contouring errors of only 1–2 mm may significantly alter treatment quality.
Margins are therefore kept extremely small.
Many intracranial SRS cases use:
PTV Margin = 0–1 mm
depending on institutional protocol.
4. Highly Conformal Planning
Treatment planning aims to maximize:
Target Coverage
Conformity Index (CI)
Gradient Index (GI)
while minimizing dose to organs at risk.
Common planning techniques include:
Dynamic Conformal Arcs
VMAT
Multiple non-coplanar arcs
Cone-based treatments
5. Image Guidance
Before irradiation, image verification is mandatory.
Depending on the machine:
CBCT
ExacTrac
CyberKnife X-ray imaging
Gamma Knife localization
Patient positioning accuracy should generally be within 1 mm.
Common Indications
SRS is primarily used for small intracranial lesions.
Examples include:
Brain Metastases
Probably the most common indication.
Patients with limited brain metastases often receive SRS instead of Whole Brain Radiotherapy.
Advantages include:
Excellent local control
Better cognitive preservation
Short treatment course
Vestibular Schwannoma (Acoustic Neuroma)
Excellent long-term tumor control while preserving neurological function.
Meningioma
Especially for:
Small lesions
Residual disease
Recurrent tumors
Arteriovenous Malformations (AVMs)
Radiation causes gradual obliteration of abnormal vessels over several years.
Pituitary Adenoma
Often used after incomplete surgical resection.
Trigeminal Neuralgia
One of the few non-oncologic indications.
Radiation targets the trigeminal nerve root entry zone to relieve severe facial pain.
Dose Prescription
Prescription depends on:
Lesion size
Histology
Location
Proximity to critical organs
Typical examples include:
Brain metastases:
18–24 Gy × 1
Vestibular schwannoma:
12–13 Gy × 1
AVM:
18–25 Gy × 1
These values vary between institutions and protocols.
Organs at Risk
Critical intracranial structures include:
Brainstem
Optic nerves
Optic chiasm
Cochlea
Eyes
Lens
Normal brain tissue
Strict dose constraints are essential because high single-fraction doses significantly increase the risk of toxicity if these limits are exceeded.
Advantages of SRS
SRS offers several important benefits:
Non-invasive treatment
Outpatient procedure
High local control rates
Minimal interruption of systemic therapy
Excellent patient convenience
Reduced exposure of normal brain tissue
Preservation of neurocognitive function compared with WBRT in selected patients
Limitations
SRS is not appropriate for every patient.
Limitations include:
Large tumor size
Diffuse disease
Extensive edema
Multiple widespread metastases
Lesions very close to critical structures
Patient selection is therefore crucial.
SRS vs SBRT
These terms are often confused.
SRS is used almost exclusively for intracranial lesions and is commonly delivered in a single fraction.
SBRT (Stereotactic Body Radiotherapy) is applied to extracranial sites such as the lung, liver, spine, adrenal gland, pancreas, and prostate, typically using 3–5 fractions, although single-fraction SBRT is used in selected cases.
The underlying principles are similar:
High precision
High dose per fraction
Image guidance
Steep dose gradients
The Role of the Medical Physicist
The medical physicist is central to every SRS program, ensuring:
Machine calibration
End-to-end testing
Small-field dosimetry
Imaging and treatment isocenter coincidence
Winston–Lutz testing
Patient-specific QA
Mechanical accuracy of the treatment unit
In SRS, an error of 1 mm can have significant dosimetric consequences, making rigorous quality assurance essential.
Conclusion
Stereotactic Radiosurgery represents the convergence of radiobiology, medical physics, advanced imaging, and engineering. Its success is not based on delivering more radiation, but on delivering radiation with extraordinary precision.
In modern radiation oncology, SRS demonstrates that accuracy is as important as dose. When high-dose treatment is combined with sub-millimeter localization and meticulous quality assurance, radiation can achieve outcomes that once required open neurosurgery.  
If you are interested in CyberKnife treatment call the most experienced team in South Florida as the CyberKnife Center of Miami for a consultation. Call 305-279-2900.
                                                          -0-
Recommended References:
Khan FM – The Physics of Radiation Therapy
Podgorsak EB – Radiation Oncology Physics
ASTRO Clinical Practice Guidelines for Brain Metastases
AAPM TG-101: Stereotactic Body Radiation Therapy
ICRU Report 91

NCCN Guidelines – Central Nervous System Cancers